Camino Pharma is focused on discovering and developing first-in-class therapies for patients suffering from cancer and CNS disorders.
Camino Pharma has raised $2.0M in total funding. The most recent round was Grant. The last funding was announced in December 2023.
Camino Pharma's investors include National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism.
Camino Pharma is headquartered in San Diego, United States.
Camino Pharma is focused on discovering and developing first-in-class therapies for patients suffering from cancer and CNS disorders.
Camino Pharma is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Camino Pharma — Funding & Investors." VCBacked, December 7, 2023, https://www.vcbacked.co/company/camino-pharma. Accessed August 14, 2026.
VCBacked. (2023). Camino Pharma — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/camino-pharma
{{cite web |title=Camino Pharma — Funding & Investors |url=https://www.vcbacked.co/company/camino-pharma |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated